William E. Rote Travere Therapeutics, Inc. (TVTX) insider trading activity

TVTX Quotes by TradingView

William E. Rote is SENIOR VICE PRESIDENT, R&D of Travere Therapeutics, Inc.. Currently has a direct ownership of 84,455 shares of TVTX, which is worth approximately $1.29 Million. The most recent transaction as insider was on Sep 09, 2024, when has been sold 4,387 shares (Common Stock) at a price of $11.52 per share, resulting in proceeds of $50,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.5K
4.63% 3M change
38.06% 12M change
Total Value Held $1.29 Million

WILLIAM E. ROTE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 09 2024
SELL
Open market or private sale
$50,538 $11.52 p/Share
4,387 Reduced 4.94%
84,455 Common Stock
Sep 05 2024
BUY
Grant, award, or other acquisition
-
6,750 Added 7.06%
88,842 Common Stock
Feb 01 2024
SELL
Open market or private sale
$41,446 $8.7 p/Share
4,764 Reduced 5.57%
80,720 Common Stock
Jan 31 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 22.63%
85,484 Common Stock
Jan 23 2024
SELL
Open market or private sale
$18,475 $8.96 p/Share
2,062 Reduced 3.3%
60,484 Common Stock
Sep 05 2023
SELL
Open market or private sale
$26,698 $14.71 p/Share
1,815 Reduced 2.88%
61,173 Common Stock
Aug 31 2023
BUY
Grant, award, or other acquisition
-
3,300 Added 4.98%
62,988 Common Stock
May 10 2023
SELL
Open market or private sale
$13,686 $16.59 p/Share
825 Reduced 1.37%
59,211 Common Stock
Feb 01 2023
SELL
Open market or private sale
$57,627 $22.25 p/Share
2,590 Reduced 4.14%
60,036 Common Stock
Jan 31 2023
BUY
Grant, award, or other acquisition
-
20,250 Added 24.43%
62,626 Common Stock
Jan 24 2023
SELL
Open market or private sale
$44,333 $21.5 p/Share
2,062 Reduced 4.64%
42,376 Common Stock
May 11 2022
SELL
Open market or private sale
$33,964 $21.73 p/Share
1,563 Reduced 3.46%
43,672 Common Stock
Jan 31 2022
SELL
Open market or private sale
$30,825 $27.4 p/Share
1,125 Reduced 2.43%
45,235 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
9,840 Added 17.51%
46,360 Common Stock
Jan 24 2022
SELL
Open market or private sale
$46,837 $24.98 p/Share
1,875 Reduced 4.88%
36,520 Common Stock
Jan 11 2022
SELL
Open market or private sale
$68,500 $27.4 p/Share
2,500 Reduced 6.11%
38,395 Common Stock
Jan 10 2022
BUY
Grant, award, or other acquisition
-
5,000 Added 10.89%
40,895 Common Stock
Aug 17 2021
SELL
Open market or private sale
$24,088 $17.12 p/Share
1,407 Reduced 3.79%
35,731 Common Stock
Aug 13 2021
BUY
Grant, award, or other acquisition
-
4,500 Added 10.81%
37,138 Common Stock
May 12 2021
SELL
Open market or private sale
$30,397 $19.46 p/Share
1,562 Reduced 4.7%
31,707 Common Stock
May 11 2021
SELL
Open market or private sale
$29,916 $19.14 p/Share
1,563 Reduced 4.49%
33,269 Common Stock
Feb 18 2021
SELL
Open market or private sale
$35,838 $28.67 p/Share
1,250 Reduced 3.46%
34,832 Common Stock
Feb 17 2021
SELL
Open market or private sale
$34,188 $27.35 p/Share
1,250 Reduced 3.35%
36,082 Common Stock
Feb 08 2021
SELL
Open market or private sale
$71,055 $31.58 p/Share
2,250 Reduced 5.68%
37,332 Common Stock
Feb 05 2021
SELL
Open market or private sale
$70,672 $31.41 p/Share
2,250 Reduced 5.38%
39,582 Common Stock
WER

William E. Rote

SENIOR VICE PRESIDENT, R&D
San Diego, CA

Track Institutional and Insider Activities on TVTX

Follow Travere Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

News

Receive news related to Travere Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TVTX